StockData
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. (WHWK) stock

WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.13+0.05 (+1.62%)

Close on Nov 18, 2026Market cap $178.44MP/E –Yield –

Whitehawk Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Whitehawk Therapeutics's price to sales ratio was 26.5× on Apr 30, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 1.4× to 36.8×, with a median of 5.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 202626.5×+18.5
2025Dec 31, 20257.9×+4.8
2024Dec 31, 20243.1×+1.0
2023Dec 29, 20232.1×−11.0
2022Dec 30, 202213.1×−23.7
2021Dec 31, 202136.8×+35.0
2019Apr 30, 20191.9×–

More Whitehawk Therapeutics figures

See a number that looks wrong?